When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Myocarditis

Última revisão: 21 Jul 2025
Última atualização: 03 Jul 2024

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • viral syndrome (prior)
  • autoimmune disease
  • infectious disease
  • drugs and toxins
Detalhes completos

Outros fatores diagnósticos

  • age <50 years
  • chest pain
  • dyspnea
  • orthopnea
  • fatigue
  • palpitations
  • rales
  • elevated neck veins
  • S3 gallop
  • sinus tachycardia
  • atrial and ventricular arrhythmias
  • tachypnea
  • hepatomegaly
  • syncope
  • fever
  • gastrointestinal issues
  • rhinorrhea
  • cough
  • S3 and S4 summation gallop
  • pericardial friction rub
  • peripheral hypoperfusion
  • hypotension
  • altered sensorium
  • lymphadenopathy
  • respiratory distress
Detalhes completos

Fatores de risco

  • infection (non-HIV)
  • HIV infection
  • autoimmune/immune-mediated diseases
  • peripartum and postpartum periods
  • drugs and toxins
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • 12-lead ECG
  • CXR
  • serum CK
  • serum CK-MB
  • serum troponin (I or T)
  • serum B-type natriuretic peptide
  • two-dimensional echocardiogram
Detalhes completos

Investigações a serem consideradas

  • endomyocardial biopsy (EMB)
  • coronary angiography
  • 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET-CT)
  • cardiac MRI
  • viral polymerase chain reaction (PCR)
Detalhes completos

Novos exames

  • MRI-guided EMB

Algoritmo de tratamento

AGUDA

hemodynamically stable: no evidence of LV systolic dysfunction

hemodynamically stable: evidence of LV systolic dysfunction

hemodynamically unstable: adults

hemodynamically unstable: children

CONTÍNUA

end-stage heart failure or refractory life-threatening arrhythmias

Colaboradores

Autores

Shriprasad R. Deshpande, MBBS, MS

Medical Director

Heart Transplant and Advanced Cardiac Therapies Program

Children's National Hospital

Associate Professor of Pediatrics

The George Washington University

Washington

DC

Declarações

SRD declares that he has no competing interests.

Bibhuti Das, ​MBBS, MD, FAAP, FACC

Director of Heart Failure and Heart Transplant

Pediatric Cardiology

University of Mississippi Medical Center

Jackson

MS

Declarações

BD declares that he has no competing interests.

Agradecimentos

Dr Shriprasad R. Deshpande and Dr Bibhuti Das would like to gratefully acknowledge Dr Katherine C. Wu, Dr James E. Harvey, and Dr Arman T. Askari, previous contributors to this topic. KCW, JEH, and ATA declare that they have no competing interests.

Revisores

David A. Leaf, MD, MPH

Professor of Medicine

School of Medicine

VA Greater Los Angeles Healthcare System

UCLA

Los Angeles

CA

Declarações

DAL declares that he has no competing interests.

John Charpie, MD, PhD

Associate Professor of Pediatrics

Medical Director

Pediatric Cardiothoracic Intensive Care Unit

University of Michigan Congenital Heart Center

Ann Arbor

MI

Declarações

JC declares that he has no competing interests.

Lokesh Tejwani, MD, FACC

Assistant Professor of Clinical Medicine

University of Missouri Hospitals and Clinics

Harry S. Truman VA Hospital

Columbia

MO

Declarações

LT declares that he has no competing interests.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Lieberman EB, Hershkowitz A, Rose NR, et al. A clinicopathologic description of myocarditis. Clin Immunol Immunopathol. 1993 Aug;68(2):191-6. Resumo

Law YM, Lal AK, Chen S, et al. Diagnosis and management of myocarditis in children: a scientific statement from the American Heart Association. Circulation. 2021 Aug 10;144(6):e123-35.Texto completo  Resumo

Bozkurt B, Colvin M, Cook J, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. 2016 Nov 3;134(23):e579-646.Texto completo  Resumo

Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3;145(18):e895-1032.Texto completo  Resumo

Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987 Jan;1(1):3-14. Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Myocarditis images
  • Diagnósticos diferenciais

    • Acute coronary syndrome
    • Dilated cardiomyopathy
    • Pericarditis
    Mais Diagnósticos diferenciais
  • Diretrizes

    • 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
    • 2022 ESC Guidelines on cardio-oncology
    Mais Diretrizes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal